The historical rank and industry rank for Ondine Biomedical's Days Inventory or its related term are showing as below:
FRA:VF5's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 183.23 * Ranked among companies with meaningful Days Inventory only.
Ondine Biomedical's Days Inventory
declined
from Dec. 2023 (613.15) to Dec. 2024 (589.88).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Ondine Biomedical's Inventory Turnover for the
six
months ended in Dec. 2024 was 0.31.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ondine Biomedical's Inventory-to-Revenue for the
six
months ended in Dec. 2024 was 1.08.
Ondine Biomedical (FRA:VF5) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Ondine Biomedical's Inventory Turnover for the
six
months ended in Dec. 2024 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ondine Biomedical's Inventory to Revenue for the
six
months ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Ondine Biomedical Days Inventory Related Terms
Ondine Biomedical Days Inventory Historical Data
* Premium members only.
The historical data trend for Ondine Biomedical's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:VF5 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Ondine Biomedical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ondine Biomedical Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ondine Biomedical's Days Inventory distribution charts can be found below:
* The bar in red indicates where Ondine Biomedical's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ondine Biomedical (FRA:VF5) has a Days Inventory of 589.88 as of Dec. 2024. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ondine Biomedical and its competitors.
Is Ondine Biomedical's Days Inventory too high?
Ondine Biomedical's current Days Inventory is 589.88. The Biotechnology industry median Days Inventory is 183.23. Ondine Biomedical's value of 589.88 is 221.9% above this industry median. Overall, Ondine Biomedical has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Ondine Biomedical's Days Inventory compare to VRTX and REGN?
Ondine Biomedical's Days Inventory of 589.88 can be compared against companies in the Biotechnology industry. The industry median Days Inventory is 183.23. Ondine Biomedical's value of 589.88 is 221.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ondine Biomedical's current Days Inventory of 589.88 is 221.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ondine Biomedical and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ondine Biomedical's current Days Inventory is 589.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ondine Biomedical stock overvalued right now?
Ondine Biomedical (FRA:VF5) has a current Days Inventory of 589.88. The current Days Inventory is 589.88 and 221.9% above the Biotechnology industry median of 183.23. Ondine Biomedical's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Ondine Biomedical (FRA:VF5), the current Days Inventory is 589.88 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
47GF Score
Get the complete analysis for FRA:VF5
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VF5 has been successfully added to your 
